AzTrials
AzTrials

Down SyndromeNCT00668980

Symbolic Representation in Young Children With Down Syndrome

An observational study of Down Syndrome, run by University of Sao Paulo at 3 sites in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to characterize the process of constitution of symbolic representation in infants with Down syndrome, as well as to investigate the relationship between gestures and the emergence of oral language. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Down Syndrome
How many people
25 participants
Where
3 sitesBrazil
Study dates
Jul 2006to Apr 2009
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Study Group - children with Down syndrome that attend speech-language therapy at the Speech Language Pathology Laboratory in Syndromes and Sensorimotor Deficits of the School of Medicine of the University of São Paulo or from the Association of Parents and Friends of Exceptional children of São José dos Campos. Control Group - typically developing children followed up in the Pediatrics Ambulatory of the University's Hospital and/or being assisted in the University' Hospital Nursery School.

Who may be able to join

  • genetic diagnosis of Down Syndrome
  • be at the 4th stage of sensorimotor period at the initial assessment
  • good health conditions
  • good results on audiologic evaluation
  • pediatric and ear, nose and throat periodic check ups.
  • good health conditions
  • be at the 4th stage of sensorimotor period at the initial assessment
  • pediatric and ear, nose and throat periodic check ups.

Who cannot join

  • submission to long term hospitalizations due to heart diseases and major respiratory airway infections, that may interfere in the child's global development
  • presence of visual or auditory important deficits
  • historic of prematurely and/or low birth weight

Trial locations and contacts

3 sites in 1 country.

Brazil3 sites
  • APAE Sao José dos Campos

    São José dos Campos, São Paulo, 12233-400

  • University Hospital

    São Paulo, São Paulo, 05360-160

  • University of Sao Paulo - School of Medicine - Department of Physiotherapy, Communication Sciences and Disorders, Occupational Therapy

    São Paulo, São Paulo, 05360-160

Other trials in Brazil

About this study

Official title: The Constitution of Symbolic Representation in Young Children With Down Syndrome

The aim of this study is to characterize the process of constitution of symbolic representation in infants with Down syndrome, as well as to investigate the relationship between gestures and the emergence of oral language. The investigators hypothesis is that children with Down syndrome could present difficulties during the constitution of symbolic representation that may be related to later deficits on expressive language, generally observed in these children.

Read the detailed description

According to the Genetic Epistemology, language development is directly related to cognitive construction. Such relationship is clearly observed after the constitution of representation that allows one individual to express his or her thinking through language.

Conditions
Down Syndrome
Keywords
Down syndrome, symbolic representation, gestures, expressive language development
Medical subject headings
Down Syndrome, Gestures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT00668980
Study groupRoleWhat they receive
Study group20 infants with Down syndrome
Control Group15 typically developing children

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Performance on monthly assessments administered after the initial evaluation

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Apr 2008 (estimated)
  2. Study startJul 2006
  3. Primary completionApr 2009
  4. Study completionApr 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00668980
Sponsor's protocol ID
06/50842-4
Status last verified
Jan 2010
First submitted
25 Apr 2008
Last updated
14 Jan 2010
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Down Syndrome, run by University of Sao Paulo at 3 sites in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jan 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Performance on monthly assessments administered after the initial evaluation (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in